Related Experiment Video
Updated: Jun 20, 2025

10:36
A Swine Model of Neonatal Asphyxia
Published on: October 11, 2011
14.3K
Enteral plasma feeding improves gut function and immunity in piglets after birth asphyxia
Mads Jacob Bagi Nordsten1, Christina L Winther2, Maria Mathilde Haugaard1
1Comparative Pediatrics and Nutrition, Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Pediatric Research
|July 21, 2024
Summary
Enteral plasma supplementation enhances survival and gut health in newborns, including those affected by birth asphyxia. This study in piglets suggests plasma may offer protective benefits for compromised infants.
Area of Science:
- Neonatal physiology
- Gastroenterology
- Immunology
Background:
- Birth asphyxia can impair newborn gut function and immunity.
- Immunomodulatory diets may protect against asphyxia-related damage.
- Pigs serve as a model for studying neonatal gut and immune responses.
Purpose of the Study:
- To investigate if enteral plasma feeding improves gut and immune functions in asphyxiated newborns.
- To assess the effects of plasma supplementation on piglets experiencing birth asphyxia.
- To explore plasma's potential as a therapeutic agent for compromised newborns.
Main Methods:
- Near-term piglets were subjected to transient birth asphyxia (ASP) or used as controls (CON).
- Piglets received either porcine plasma or a vehicle control via enteral feeding.
- Dietary interventions included bovine colostrum and formula over 72 hours.
Main Results:
- Asphyxiated piglets exhibited reduced respiratory stability, pH, weight gain, and survival.
- Plasma supplementation decreased gut lesions, permeability, and inflammatory cytokines.
- Plasma improved villous morphology, enzyme activity, and immune response to bacterial stimulation.
Conclusions:
- Dietary plasma improves survival, gut function, and immunity in both normal and asphyxiated newborns.
- Plasma components may mediate protective gut effects, warranting further identification.
- Plasma holds potential for novel oral therapies for compromised newborn infants and piglets.

